Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22915657 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial
Condition: Nausea
Interventions: Drug: aprepitant;   Drug: dexamethasone;   Drug: granisetron hydrochloride;   Drug: palonosetron hydrochloride;   Drug: prochlorperazine;   Drug: placebo

Indicates status has not been verified in more than two years